CNSPCNS Pharmaceuticals, Inc.

Nasdaq cnspharma.com


$ 1.70 $ -0.14 (-7.61 %)    

Thursday, 27-Jun-2024 13:46:40 EDT
QQQ $ 481.81 $ 1.83 (0.38 %)
DIA $ 392.15 $ 1.36 (0.35 %)
SPY $ 546.12 $ 0.63 (0.12 %)
TLT $ 93.60 $ 0.17 (0.18 %)
GLD $ 215.02 $ 0.31 (0.14 %)
$ 1.84
$ 1.75
$ 1.66 x 100
$ 0.00 x 0
$ 1.63 - $ 1.78
$ 1.61 - $ 137.50
1,518,512
na
320,627
$ 49.60
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-03-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 02-12-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 12-20-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cns-pharmaceuticals-announces-pricing-of-registered-direct-offering-and-concurrent-private-placement-of-568k-shares-at-245share

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in t...

 why-cns-pharmaceuticals-shares-are-getting-hammered

CNS Pharmaceuticals shares are trading lower by 33.4% during Monday's session. The company announced a 1-for-50 reverse spl...

 cns-pharmaceuticals-q1-eps-041-up-from-259-yoy

CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(0.41) per share. This is a 84.17 percent increase over losses ...